X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Nutraceuticals 2025 takes position on international trade fair calendar, with fair slated for 5th and 6th March at new venue

Content Team by Content Team
7th November 2024
in Press Statements

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Valencia – The next Nutraceuticals Europe Summit & Expo takes place on 5th and 6th March 2025 and professionals, producers, distributors and customers in the functional ingredients, novel foods and finished products sector are already being invited to attend. With its new nomadic hat on, the organizers have opted to stage the fair at Ifema, in Madrid, in odd-numbered years, whilst it will return to the Barcelona International Convention Centre – BICC – in even-numbered years. Staging the fair in Barcelona enabled it to position itself as the leading event for the industry, both within Spain and in the international arena, and it will be returning there in 2026.

On this point the fair’s director, Esther Cano, underscores that “this change in location is a response to both our exhibitors’ and our visitors’ needs”. Cano and her technical team have begun preparations for this next edition and are aiming to further boost Nutraceuticals Europe Summit & Expo as the leading platform for presenting the latest advances in research in this field and launching them onto the market.

 

With that aim in mind, the fair will again be featuring its space dedicated to training, scientific innovation and analyzing trends, the ‘Seminar Theatre’. The Theatre is also a hub where high-level internationally recognised speakers will not just be talking about the latest market news but will also be addressing issues relating to innovation in nutraceutical ingredients, new areas of research and nutritional product development and trends in the health and wellness market.

As to the commercial exhibition itself, Nutraceuticals Europe Summit & Expo is seeking to surpass the results the last edition of the fair achieved, when it brought together 113 exhibitors, 13% more than in 2023. 40% of exhibitors were foreign companies, hailing from Argentina, Belgium, China, Colombia, Denmark, France, Germany, Great Britain, Holland, India, Italy, the Netherlands, Poland, Portugal Singapore and Switzerland. This most recent fair also saw a significant increase in the number of professionals attending: 21.25% more than attended the previous edition. According to Cano, “we have some very ambitious targets, we are committed to exceeding them and to making Nutraceuticals Europe Summit & Expo an even more successful experience than in previous years”.

5th and 6th March 2025, Hall 1, Ifema, Madrid.

Previous Post

UK Medicine Manufacturing Regulatory Framework For Care

Next Post

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies - Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies - Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In